tetradecanoylphorbol acetate has been researched along with Carotid Artery Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beloqui, O; Benito-Martin, A; Blanco-Colio, LM; Burillo, E; Egido, J; Fernandez-Garcia, CE; Lindholt, JS; Llamas-Granda, P; Madrigal-Matute, J; Martin-Ventura, JL; Ortiz, A; Zalba, G | 1 |
| Castro, G; Copin, C; Fruchart, JC; Furman, C; Jaye, M; Larigauderie, G; Lasselin, C; Rouis, M | 1 |
| Bretschneider, E; Censarek, P; Fischer, JW; Meyer-Kirchrath, J; Pape, R; Rabausch, K; Sarbia, M; Schrör, K; Weber, AA | 1 |
3 other study(ies) available for tetradecanoylphorbol acetate and Carotid Artery Diseases
| Article | Year |
|---|---|
Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis.
Topics: Aged; Biomarkers; Carotid Artery Diseases; Carotid Intima-Media Thickness; Case-Control Studies; Cell Line; Female; Follow-Up Studies; Galectin 3; Humans; In Vitro Techniques; Inflammation; Macrophages; Male; Middle Aged; Monocytes; NADPH Oxidases; Oxidative Stress; Peripheral Arterial Disease; Prognosis; Tetradecanoylphorbol Acetate | 2014 |
Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages: potential role in atherogenesis.
Topics: Apolipoprotein A-I; Carotid Artery Diseases; Cell Differentiation; Cell Line; Cholesterol; Cholesterol Esters; DNA, Complementary; Endarterectomy, Carotid; Foam Cells; Gene Silencing; Humans; Lipid Metabolism; Lipoproteins, LDL; Macrophages; Membrane Proteins; Monocytes; Peptides; Perilipin-2; Receptors, Immunologic; Receptors, Scavenger; RNA, Messenger; RNA, Small Interfering; Tetradecanoylphorbol Acetate; Transfection; Triglycerides | 2004 |
Regulation of thrombomodulin expression in human vascular smooth muscle cells by COX-2-derived prostaglandins.
Topics: Alprostadil; Blood Coagulation; Bucladesine; Carotid Artery Diseases; Carotid Artery, Internal; Cells, Cultured; Colforsin; Coronary Vessels; Culture Media, Serum-Free; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Epoprostenol; Etoricoxib; Gene Expression Profiling; Gene Expression Regulation; Humans; Iloprost; Isoquinolines; Mammary Arteries; Membrane Proteins; Models, Biological; Myocytes, Smooth Muscle; Oligonucleotide Array Sequence Analysis; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyridines; Receptors, Prostaglandin; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; RNA, Messenger; Saphenous Vein; Second Messenger Systems; Sulfonamides; Sulfones; Tetradecanoylphorbol Acetate; Thrombomodulin; Thrombophilia; Vasodilator Agents | 2005 |